Birth weight was negatively correlated with plasma ghrelin, insulin resistance, and coenzyme Q10 levels in overweight children.
The purpose of this study was to investigate the relationship between birth weight and appetite related hormones, insulin resistance, and antioxidant status in overweight children aged 9-10 years. Thirty-four healthy overweight children (18 boys, 16 girls) were evaluated with respect to anthropometric measurement, lipid profiles, leptin, ghrelin, glucose, insulin, C-peptide, lipid soluble vitamins, and antioxidant enzyme activities. I found that birth weight was negatively correlated with insulin resistance parameters, ghrelin, and coenzyme Q10 levels. There was a significant positive correlation between present BMI and leptin level, while a negative correlation was noted between the BMI and α-tocopherol and lycopene levels. When total subjects were classified into three groups by tertiles of birth weight, the lowest tertile of birth weight (LTB) group showed higher levels of fasting glucose, HOMA-IR, and ghrelin level than the highest tertile of birth weight (HTB) groups. On the other hand, HTB group showed an increased oxidative stress (decreased coenzyme Q10 level and catalase activity) compared to the LTB group. In conclusion, plasma ghrelin level might play an important role in accelerated growth in overweight children with LTB. Increased insulin resistance is present in overweight children with LTB, while decreased coenzyme Q10 and catalase activity in overweight children with HTB. These results suggest that birth weight might be an important factor for determination of treatment for obesity related complications in childhood obesity.
Park
Eunju
E
Department of Food & Nutrition, Kyungnam University, 449 Woryeong-dong, Masanhappo-gu, Changwon-si, Gyeongnam 631-701, Korea.
Int J Vitam Nutr Res. 1995;65(1):31-5
7657478
Eur J Endocrinol. 2003 Aug;149(2):111-6
12887287
Clin Endocrinol (Oxf). 2009 Jan;70(1):41-6
18419783
Ann N Y Acad Sci. 1972 Dec 18;203:223-36
4633111
Eur Heart J. 1997 Jun;18(6):883-4
9183571
J Clin Endocrinol Metab. 2009 Nov;94(11):4448-52
19820011
Eur J Biochem. 1974 Sep 16;47(3):469-74
4215654
Am J Epidemiol. 2006 Oct 15;164(8):787-93
16840521
Circulation. 2003 Mar 18;107(10):1448-53
12642369
J Clin Endocrinol Metab. 2001 Jan;86(1):267-72
11232011
Horm Res. 2009;71(2):65-74
19129710
Arq Bras Cardiol. 2009 Sep;93(3):261-7
19851654
J Clin Endocrinol Metab. 2002 Dec;87(12):5830-3
12466394
J Clin Endocrinol Metab. 2002 Jan;87(1):240-4
11788653
Horm Res. 2006;65 Suppl 3:65-9
16612116
Horm Res. 2006;65 Suppl 3:137-43
16612127
Ann Clin Biochem. 1986 Sep;23 ( Pt 5):514-20
3767286
Am J Clin Nutr. 2002 Apr;75(4):676-82
11916753
Eur J Obstet Gynecol Reprod Biol. 2008 Dec;141(2):95-9
18760523
Isr Med Assoc J. 2002 Aug;4(8):590-3
12183861
Int J Obes Relat Metab Disord. 2001 Oct;25(10):1537-45
11673778
Am J Clin Nutr. 1994 Feb;59(2):307-16
8310979
Physiol Res. 2003;52(1):61-6
12625808
Physiol Behav. 2006 Aug 30;89(1):71-84
16859720
Acta Biomed. 2009 Apr;80(1):21-8
19705616
J Nutr. 2005 May;135(5):1320-5
15867333
Scand J Clin Lab Invest. 2006;66(5):363-70
16901847
Diabetes. 2001 Apr;50(4):707-9
11289032
Pediatrics. 2009 Aug;124(2):695-702
19651586
J Endocrinol Invest. 2002 May;25(5):RC13-5
12035950
Diabetes Care. 2008 May;31(5):1031-6
18223033
Curr Opin Endocrinol Diabetes Obes. 2008 Feb;15(1):21-9
18185059
JAMA. 2000 Dec 20;284(23):3043-5
11122593
Eur J Endocrinol. 2008 Nov;159(5):555-60
18703566
Eur J Endocrinol. 2001 Nov;145(5):669-73
11720888
Pediatrics. 2005 Mar;115(3):e290-6
15741354
J Clin Endocrinol Metab. 2007 Apr;92(4):1372-8
17264184
J Pediatr. 1999 Feb;134(2):160-5
9931523
Diabetes. 1988 Dec;37(12):1595-607
3056758
Diabetes Care. 1999 Jun;22(6):944-50
10372247
J Clin Endocrinol Metab. 2004 Apr;89(4):1630-5
15070922
Diabetologia. 1985 Jul;28(7):412-9
3899825